nach oben

Pediatric Nephrology

Erschienen in:

01.02.2008 | Brief Report

Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker

verfasst von: Claudio Celentano, Federico Prefumo, Elena di Vera, Annamaria Iannicco, Davide Pio Gallo, Marco Liberati

Erschienen in: Pediatric Nephrology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

We report on a case of fetal toxicity due to maternal treatment with olmesartan medoxomil. At 29 weeks’ gestation, oligohydramnios was found, although the fetus had normal kidneys on ultrasound evaluation. Withdrawal of olmesartan medoxomil, maternal rehydration, and a single dose of furosemide reversed the renal impairment. After term delivery, the neonate was confirmed to have normal renal function. The case suggested that fetal renal impairment due to olmesartan medoxomil may be reversible.

Cooke CE, Fatodu H (2006) Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a Medicaid managed care organization. J Manag Care Pharm 12:649–655PubMed

Pryde PG, Sedman AB, Nugent CE, Barr M Jr (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575–1582PubMed

Saji H, Yamanaka M, Hagiwara A, Ijiri R (2001) Losartan and fetal toxic effects. Lancet 357:363PubMedCrossRef

Alwan S, Polifka JE, Friedman JM (2005) Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 73:123–130PubMedCrossRef

Daikha-Dahmane F, Levy-Beff E, Jugie M, Lenclen R (2006) Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. Pediatr Nephrol 21:729–732PubMedCrossRef

Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82:23–28PubMedCrossRef

Prandota J (2001) Clinical pharmacology of furosemide in children: a supplement. Am J Ther 8:275–289PubMedCrossRef

Kelly TF, Moore TR, Brace RA (1993) Hemodynamic and fluid responses to furosemide infusion in the ovine fetus. Am J Obstet Gynecol 168:260–268PubMed

Flack NJ, Sepulveda W, Bower S, Fisk NM (1995) Acute maternal hydration in third-trimester oligohydramnios: effects on amniotic fluid volume, uteroplacental perfusion, and fetal blood flow and urine output. Am J Obstet Gynecol 173:1186–1191PubMedCrossRef

10.

Iura T, Makinoda S, Fujita S, Matsuzawa S, Waseda T, Oshima K, Tomizawa H (2005) Analysis of the renal artery hemodynamics in normal fetuses using the color Doppler method. Fetal Diagn Ther 20:86–90PubMedCrossRef

11.

Barr M (1994) Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50:399–409PubMedCrossRef

12.

Spence SG, Allen HL, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS (1995) Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51:367–382PubMedCrossRef

Titel: Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker
verfasst von: Claudio Celentano
Federico Prefumo
Elena di Vera
Annamaria Iannicco
Davide Pio Gallo
Marco Liberati
Publikationsdatum: 01.02.2008
Verlag: Springer-Verlag
Erschienen in: Pediatric Nephrology / Ausgabe 2/2008
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-007-0618-8

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker

Abstract

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity

The third World Kidney Day: looking back and thinking forward

Tolterodine and imipramine in refractory enuresis; a placebo-controlled crossover study

A milder variant of Pierson syndrome

Central venous lines for chronic hemodialysis: survey of the Midwest Pediatric Nephrology Consortium

Diet does not explain the high prevalence of dyslipidaemia in paediatric renal transplant recipients

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie